Clinical Trial Update: A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy [Phase 2]

View source ↗

Summary

A Phase II study evaluating Zuberitamab injection in patients with primary membranous nephropathy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Zuberitamab (Zuberitamab)

Snippet

Sponsor: BioRay Pharmaceutical Co., Ltd. | Conditions: Primary Membranous Nephropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING